Correction: Profiling Chinese children with symptoms of SpLD, ADHD, or ASD: a transdiagnostic and biopsychosocial study
By
Duo Liu
Ziqian Wei
Urs Maurer
Kevin Kien Hoa Chung
Jesus Alfonso D. Datu
Liory Fern-Pollak
Taeko Wydell
Winnie Wan-Yee Tso
Fenghua Sun
Lirong Luo
Li-Chih Wang
Yen Na Yum
Guandong Xu
Su Li
April 15, 2026
Clinical Scorecard: Correction: Analyzing Symptoms of SpLD, ADHD, and ASD in Chinese Children: A Biopsychosocial and Transdiagnostic Approach
At a Glance
Category Detail
Condition Specific Learning Disabilities (SpLD), Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD) Key Mechanisms Biopsychosocial and transdiagnostic approaches Target Population Chinese children Care Setting Clinical research
Key Highlights
Correction of author contributions Focus on symptoms of SpLD, ADHD, and ASD Utilization of a biopsychosocial framework Emphasis on transdiagnostic approaches Collaboration among multiple authors Guideline-Based Recommendations
Diagnosis
Utilize comprehensive assessments for accurate diagnosis of SpLD, ADHD, and ASD. Management
Implement individualized intervention strategies based on the biopsychosocial model. Monitoring & Follow-up
Regularly assess symptom progression and treatment efficacy. Risks
Consider potential comorbidities and their impact on treatment outcomes. Patient & Prescribing Data
Children diagnosed with SpLD, ADHD, and ASD in China
Focus on tailored interventions that address specific symptoms and challenges.
Clinical Best Practices
Engage multidisciplinary teams for comprehensive care. Incorporate family involvement in treatment planning. Utilize evidence-based practices for symptom management. References
